Current Vascular Pharmacology
Title:Meet Our Regional Editor
Volume: 16 Issue: 4
Author(s): Greg J. Dusting
Affiliation:
Export Options
About this article
Cite this article as:
Dusting J. Greg , Meet Our Regional Editor, Current Vascular Pharmacology 2018; 16 (4) . https://dx.doi.org/10.2174/157016111604180517091313
DOI https://dx.doi.org/10.2174/157016111604180517091313 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A New Practice: Study on the Molecular Mechanism of Traditional Chinese Medicine by Computational Pharmacology Methods: Part 2: Pharmacodynamic Modeling and Distribution on Ligand-Target Space of Effective Components
Letters in Drug Design & Discovery Fibrinolytic Therapy in Acute Stroke
Current Cardiology Reviews Subject Index To Volume 4
Cardiovascular & Hematological Agents in Medicinal Chemistry Therapeutic Modulation of Growth Factors and Cytokines in Regenerative Medicine
Current Pharmaceutical Design TA-65, A Telomerase Activator improves Cardiovascular Markers in Patients with Metabolic Syndrome
Current Pharmaceutical Design Migraine: Pathophysiology, Pharmacology, Treatment and Future Trends
Current Vascular Pharmacology Acute Coronary Syndromes in Patients with Atrial Fibrillation and Heart Failure. Could Novel Oral Anticoagulants be the Solution of the Optimal Antithrombotic Therapy Puzzle?
Cardiovascular & Hematological Agents in Medicinal Chemistry Investigation of Anticholinesterase Activity of a Series of Salvia Extracts and the Constituents of Salvia staminea
The Natural Products Journal Advances in Drug Therapy for Systemic Lupus Erythematosus
Current Medicinal Chemistry Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease
Current Alzheimer Research B Cell Modulation Strategies in Autoimmunity: The SLE Example
Current Pharmaceutical Design Non Pregnant Human Uterus as Source of Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Simultaneous Determination of Amlodipine and Irbesartan in their Pharmaceutical Formulations by Square-Wave Voltammetry
Combinatorial Chemistry & High Throughput Screening Prostacyclin Analogues: Prevention of Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry PKC Delta and Epsilon in Drug Targeting and Therapeutics
Recent Patents on DNA & Gene Sequences Safety of New Oral Anticoagulants for Patients with Chronic Kidney Disease
Current Pharmaceutical Design Targeting PPAR Isoforms Following CNS Injury
Current Drug Targets Implementation of High Throughput Experimentation Techniques for Kinetic Reaction Testing
Combinatorial Chemistry & High Throughput Screening Crosstalk between Inflammation and Coagulation: The Lessons of Sepsis
Current Vascular Pharmacology Familial Hypercholesterolaemia Registry in the MENA Region
Current Vascular Pharmacology